Recognition of Plausible Therapeutic Agents to Combat COVID-19: An Omics Data Based Combined Approach

Abstract excerpt

Coronavirus disease-2019 (COVID-19) has become an immense threat to global public health. The causative agent of this disease is a novel zoonotic pathogen called Severe Acute Respiratory Syndrome related Coronavirus-2 (SARS-CoV-2). Since this is a newly evolved pathogen, very limited information is available to develop effective therapeutics against this deadly virus. Although bioinformatics based analysis could b...

Topics

Open a Topic to create a Post that cites this publication.

• Angiotensin-Converting Enzyme 2
• Clinical Trials as Topic
• COVID-19 Drug Treatment
• interferon and immune responses
• Metabolomics and Mass Spectrometry Studies
• SARS-CoV-2 and COVID-19 Research
• SARS-CoV-2 detection and testing
• vaccines and immunoinformatics approaches

Identifiers and source

Literature Corpus work

71a803c8-ff17-5f68-8554-05fd6d57e4da

DOI

10.21203/rs.3.rs-25807/v1